Table 2 Susceptibility antimicrobial against P. aeruginosa
From: Molecular epidemiology of carbapenem-resistant gram-negative bacilli in Ecuador
P aeruginosa blaVIM n = 8 | P.aeruginosa mCIM negative n = 3 | P. aeruginosa n = 11 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Antimicrobials | Susceptible | MIC50 µg/ml | MIC90 µg/ml | Susceptible | MIC50 µg/ml | MIC90 µg/ml | Susceptible | |||
No | % | No | % | No | % | |||||
AK | 4 | 50 | 4 | 32 | 2 | 66.67 | 16 | 16 | 6 | 54.54 |
GN | 2 | 25 | ≥ 32 | ≥ 32 | 1 | 33.33 | 4 | 8 | 3 | 27.27 |
CIP | 1 | 12.5 | ≥ 4 | ≥ 4 | 1 | 33.33 | 0.5 | ≥ 4 | 1 | 9.09 |
COL | 4 | 50 | 2 | ≥ 8 | 3 | 100.00 | 1 | 1 | 7 | 63.63 |
CAZ/AVI | NT | NT | NT | NT | 3a | 100.00 | DD | DD | 3a | 100 |
MER/VAR | NT | NT | NT | NT | 3a | 100.00 | 0.5 | 1 | 3a | 100 |
CAZ | 0 | 0 | ≥ 64 | ≥ 64 | 2 | 66.67 | 4 | ≥ 64 | 2 | 18.18 |
FEP | 0 | 0 | ≥ 32 | ≥ 32 | 1 | 33.33 | 8 | ≥ 32 | 1 | 9.09 |
IMP | 0 | 0 | ≥ 16 | ≥ 16 | 0 | 0.00 | ≥ 16 | ≥ 16 | 0 | 0 |
MER | 0 | 0 | ≥ 16 | ≥ 16 | 0 | 0.00 | ≥ 16 | ≥ 16 | 0 | 0 |
CEF/TAZ | 0 | 0 | > 256 | > 256 | 3 | 100.00 | 1.5 | 4 | 3 | 27.27 |
PTZ | 0 | 0 | ≥ 128/4 | ≥ 128/4 | 0 | 0.00 | ≥ 128/4 | ≥ 128/4 | 0 | 0 |